Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionInvesco Ltd.
Latest Disclosed Ownership823,604 shares
Latest Disclosed Value $ 164,432,539
Invesco Ltd. reports 59.47% increase in ownership of LGND / Ligand Pharmaceuticals Incorporated

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 823,604 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $164,432,539 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 516,464 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 59.47% during the quarter. The current value of the position is $193,052,778 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 823,604 307,140 59.47 164,433 68.39 0.0031
2026-02-19 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 516,464 138,169 36.52 97,648 45.72 0.0150
2025-11-13 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 378,295 148,437 64.58 67,011 156.45 0.0106
2025-08-13 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 229,858 27,030 13.33 26,130 22.53 0.0044
2025-05-12 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 202,828 8,473 4.36 21,325 2.40 0.0040
2025-02-13 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 194,355 5,627 2.98 20,825 10.25 0.0039
2024-11-12 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 188,728 15,917 9.21 18,890 29.72 0.0036
2024-08-13 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 172,811 -42,284 -19.66 14,561 -7.39 0.0031
2024-05-14 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 215,095 194 0.09 15,723 2.44 0.0034
2024-02-13 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 214,901 -3,886 -1.78 15,348 17.08 0.0037
2023-11-13 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 218,787 -3,196 -1.44 13,110 -18.09 0.0035
2023-08-11 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 221,983 -4,120 -1.82 16,005 -3.78 0.0042
2023-05-12 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 226,103 -783 -0.35 16,632 9.75 0.0046
2023-02-13 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 226,886 35,815 18.74 15,156 -7.89 0.0044
2022-11-14 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 191,071 -27,963 -12.77 16,453 -15.80 0.0053
2022-08-15 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 219,034 24,468 12.58 19,541 -10.71 0.0059
2022-05-16 2022-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 194,566 -14,446 -6.91 21,886 -32.21 0.0056
2022-02-14 2021-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 209,012 -62,359 -22.98 32,284 -14.61 0.0078
2021-11-15 2021-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 271,371 33,684 14.17 37,807 21.25 0.0096
2021-08-17 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 237,687 36,919 18.39 31,182 1.88 0.0077
2021-05-17 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 200,768 6,952 3.59 30,608 58.80 0.0082
2021-02-16 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 193,816 9,234 5.00 19,275 9.55 0.0056
2020-11-16 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 184,582 28,541 18.29 17,595 0.81 0.0059
2020-08-14 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 156,041 5,745 3.82 17,454 59.69 0.0062
2020-05-15 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 150,296 -48,660 -24.46 10,930 -47.32 0.0046
2020-02-14 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 198,956 169,023 564.67 20,749 596.28 0.0064
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 29,933 -337,080 -91.84 2,980 -92.89 0.0008
2019-08-14 2019-06-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 367,013 325,273 779.28 41,895 698.46 0.0108
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 367,013 -39,895 41,895
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 41,740 -85,432 -67.18 5,247 -69.59 0.0018
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 127,172 -315,384 -71.26 17,257 -85.79 0.0066
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 442,556 147,169 49.82 121,477 98.51 0.0382
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 295,387 74,445 33.69 61,195 67.70 0.0203
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 220,942 10,425 4.95 36,491 26.59 0.0136
2018-02-14 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 210,517 10,973 5.50 28,826 6.10 0.0104
2017-11-14 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 199,544 -17,974 -8.26 27,168 2.88 0.0100
2017-08-14 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 217,518 -139,067 -39.00 26,407 -30.03 0.0082
2017-05-15 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 356,585 -55,605 -13.49 37,741 -9.89 0.0124
2017-02-14 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 412,190 -84,308 -16.98 41,883 -17.35 0.0141
2016-11-14 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 496,498 24,385 5.17 50,673 -10.01 0.0174
2016-08-15 2016-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 472,113 -99,396 -17.39 56,310 -8.00 0.0207
2016-05-16 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 571,509 -168,567 -22.78 61,204 -23.72 0.0249
2016-02-16 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 740,076 -169,110 -18.60 80,239 3.04 0.0320
2015-11-16 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 909,186 -37,834 -4.00 77,872 -18.50 0.0330
2015-08-14 2015-06-30 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 947,020 -206,033 -17.87 95,554 7.47 0.0375
2015-05-15 2015-03-31 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 1,153,053 243,631 26.79 88,912 83.74 0.0344
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 909,422 109,377 13.67 48,390 28.72 0.0187
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 800,045 254,929 46.77 37,594 10.72 0.0150
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 545,116 -96,681 -15.06 33,955 -21.35 0.0134
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 641,797 107,833 20.19 43,173 53.72 0.0175
2014-02-13 2013-12-31 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 533,964 48,260 9.94 28,086 33.61 0.0112
2013-11-13 2013-09-30 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 485,704 -97,825 -16.76 21,021 -3.68 0.0091
2013-08-14 2013-06-30 13F LIGAND PHARMACEUTICALS-CL B COMMON 53220K504 583,529 583,529 21,824 0.0102
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.